Which ASX ETFs hold Vertex Pharmaceuticals Inc (VRTX)?
As at Q3 2026, VRTX is among the most widely held stocks across ASX-listed ETFs, appearing in approximately 30 ETFs. Its largest single position is approximately 2.32% in ESGI (Vaneck MSCI International Sustainable Equity ETF). General information only, not financial advice.
General information only, not financial advice. ETFLens does not hold an AFSL. Always read the relevant PDS and consider seeking advice from a licensed financial adviser.
All weights are approximate, drawn from each fund's published holdings as at Q3 2026, and change as funds rebalance.
| ETF | Fund | Category | Weight |
|---|---|---|---|
| ESGI | Vaneck MSCI International Sustainable Equity ETF | ESG / Ethical | approx. 2.32% |
| HLTH | VanEck Global Healthcare Leaders ETF | Thematic | approx. 2.08% |
| QLTY | Betashares Global Quality Leaders ETF | Global Broad Market | approx. 1.99% |
| HQLT | Betashares Global Quality Leaders ETF - Currency Hedged | Thematic | approx. 1.99% |
| DRUG | Betashares Global Healthcare Currency Hedged ETF | Thematic | approx. 1.57% |
| QNDQ | BetaShares NASDAQ 100 Equal Weight ETF | Thematic | approx. 1.20% |
| CURE | Global X S&P Biotech ETF | Thematic | approx. 1.17% |
| QYLD | Global X Nasdaq 100 Covered Call ETF | US Shares | approx. 0.59% |
| NDQ | Betashares Nasdaq 100 ETF | US Shares | approx. 0.59% |
| HNDQ | Betashares Nasdaq 100 ETF (Currency Hedged) | US Shares | approx. 0.59% |
| WVOL | iShares Edge MSCI World Minimum Volatility ETF | Thematic | approx. 0.43% |
| GHRP | Global X S&P World ex Australia GARP (Currency Hedged) ETF | Global Broad Market | approx. 0.42% |
| GARP | Global X S&P World ex Australia GARP ETF | Global Broad Market | approx. 0.42% |
| QUAL | VanEck MSCI International Quality ETF | Global Broad Market | approx. 0.41% |
| QHAL | VanEck MSCI International Quality (AUD Hedged) ETF | Global Broad Market | approx. 0.41% |
| QMIX | SPDR MSCI World Quality Mix ETF | Thematic | approx. 0.31% |
| IHWL | iShares Core MSCI World ex Australia ESG (AUD Hedged) ETF | ESG / Ethical | approx. 0.30% |
| IWLD | iShares Core MSCI World ex Australia ESG ETF | Global Broad Market | approx. 0.29% |
| HETH | Betashares Global Sustainability Leaders ETF - Currency Hedged | ESG / Ethical | approx. 0.27% |
| ETHI | Betashares Global Sustainability Leaders ETF | ESG / Ethical | approx. 0.27% |
| QUS | Betashares S&P 500 Equal Weight ETF | Thematic | approx. 0.23% |
| HQUS | Betashares S&P 500 Equal Weight Currency Hedged ETF | Thematic | approx. 0.23% |
| UYLD | Global X S&P 500 Covered Call ETF | US Shares | approx. 0.20% |
| V500 | Vanguard S&P 500 US Shares Index ETF | US Shares | approx. 0.20% |
| SPY | State Street SPDR S&P 500 ETF Trust | US Shares | approx. 0.20% |
| V5AH | Vanguard S&P 500 US Shares Index (Hedged) ETF | US Shares | approx. 0.20% |
| VTS | Vanguard US Total Market Shares Index ETF | US Shares | approx. 0.19% |
| VESG | Vanguard Ethically Conscious International Shares Index ETF | ESG / Ethical | approx. 0.18% |
| VGS | Vanguard MSCI Index International Shares ETF | Global Broad Market | approx. 0.15% |
| BGBL | Betashares Global Shares ETF | Global Broad Market | approx. 0.15% |
| WRLD | Betashares Managed Risk Global Share Fund (managed fund) | Global Broad Market | approx. 0.15% |
| HGBL | Betashares Global Shares Currency Hedged ETF | Global Broad Market | approx. 0.15% |
| VGAD | Vanguard MSCI Index International Shares (Hedged) ETF | Global Broad Market | approx. 0.14% |
Want to see what any of these funds overlap with? Try the free ETF overlap checker, or browse the most widely held stocks.
Hold more than one of these? See your combined VRTX exposure across all your ETFs with the Stock X-Ray.
VRTX in ETFs: frequently asked questions
Which ASX ETFs hold VRTX?
Vertex Pharmaceuticals Inc (VRTX) is held by approximately 30 ASX-listed ETFs, including ESGI, HLTH, QLTY, HQLT, DRUG. General information only.
Which ETF has the largest VRTX weighting?
ESGI (Vaneck MSCI International Sustainable Equity ETF) has the largest VRTX position at approximately 2.32% of the fund, as at Q3 2026. Past weightings are not a reliable indicator of future weightings.